Knoll Capital Management as of Dec. 31, 2015
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 21 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 78.8 | $213M | 4.4M | 48.34 | |
| Ampio Pharmaceuticals | 4.4 | $12M | 3.4M | 3.50 | |
| Synthetic Biologics | 3.2 | $8.6M | 3.7M | 2.29 | |
| Alcobra | 2.6 | $7.0M | 1.1M | 6.28 | |
| Cempra | 2.1 | $5.6M | 181k | 31.13 | |
| Abeona Therapeutics | 1.7 | $4.6M | 1.4M | 3.36 | |
| Corbus Pharmaceuticals Hldgs | 1.6 | $4.2M | 2.6M | 1.65 | |
| Newlink Genetics Corporation | 1.4 | $3.7M | 102k | 36.39 | |
| Advaxis | 1.0 | $2.8M | 275k | 10.06 | |
| Vascular Biologics | 0.7 | $1.8M | 333k | 5.26 | |
| Bio Blast Pharma | 0.5 | $1.3M | 338k | 3.88 | |
| Ohr Pharmaceutical | 0.5 | $1.3M | 205k | 6.14 | |
| Keryx Biopharmaceuticals | 0.4 | $1.0M | 200k | 5.05 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $921k | 136k | 6.78 | |
| Advaxis | 0.3 | $798k | 113k | 7.09 | |
| Caladrius Biosciences | 0.2 | $600k | 556k | 1.08 | |
| Galmed Pharmaceuticals | 0.2 | $495k | 65k | 7.62 | |
| Champions Oncology (CSBR) | 0.1 | $397k | 111k | 3.57 | |
| Evoke Pharma | 0.1 | $184k | 56k | 3.31 | |
| Zosano Pharma | 0.0 | $42k | 19k | 2.26 | |
| Aptose Biosciences | 0.0 | $31k | 12k | 2.60 |
